Clinical Cancer Research CR Balducci Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hearle, N.
Right arrow Articles by Houlston, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hearle, N.
Right arrow Articles by Houlston, R. S.
Clinical Cancer Research Vol. 12, 3209-3215, May 15, 2006
© 2006 American Association for Cancer Research


Cancer Prevention

Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome

Nicholas Hearle1, Valérie Schumacher2, Fred H. Menko3, Sylviane Olschwang5, Lisa A. Boardman6, Johan J.P. Gille3, Josbert J. Keller4, Anne Marie Westerman7, Rodney J. Scott8, Wendy Lim1, Jill D. Trimbath9, Francis M. Giardiello9, Stephen B. Gruber10, G. Johan A. Offerhaus4, Felix W.M. de Rooij7, J.H. Paul Wilson7, Anika Hansmann2, Gabriela Möslein11, Brigitte Royer-Pokora2, Tilman Vogel12, Robin K.S. Phillips13, Allan D. Spigelman14 and Richard S. Houlston1

Authors' Affiliations: 1 Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 2 Institute of Human Genetics, Heinrich-Heine University, Düsseldorf, Germany; 3 Department of Clinical Genetics and Human Genetics, VU University Medical Centre; 4 Department of Pathology, Academic Medical Centre, Amsterdam, the Netherlands, 5 Institut Paoli-Calmettes, Institut National de la Sante et de la Recherche Medicale UMR 599, Marseilles, France; 6 Division of Gastroenterology, Department of Internal Medicine, Mayo Clinic, Mayo Foundation, Rochester, Minnesota; 7 Department of Internal Medicine, Erasmus MC University Medical Centre, Rotterdam, the Netherlands; 8 Discipline of Medical Genetics, Faculty of Health, Newcastle and Hunter Medical Research Institute, Newcastle, New South Wales, Australia; 9 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; 10 Division of Molecular Medicine and Genetics, University of Michigan, Ann Arbor, Michigan; 11 Department of General and Visceral Surgery, St. Josefs-Hospital Bochum-Linden, Bochum, Germany; 12 Department of General, Visceral and Thoracic Surgery, Klinken Maria Hilf, Mönchengladbach, Germany; 13 Polyposis Registry, St. Mark's Hospital, Harrow, United Kingdom; and 14 Professorial Surgical Unit, Faculty of Medicine, St. Vincent's Hospital Clinical School, University of New South Wales; Hunter Family Cancer Service and New South Wales and Australian Capital Territory Hereditary Cancer Registries, Sydney, New South Wales, Australia

Requests for reprints: Richard S. Houlston, Section of Cancer Genetics, Brookes Lawley Building, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, United Kingdom. Phone: 44-20-8722-4175; Fax: 44-20-8722-4359; E-mail: Richard.Houlston{at}icr.ac.uk.

Background: Although an increased cancer risk in Peutz-Jeghers syndrome is established, data on the spectrum of tumors associated with the disease and the influence of germ-line STK11/LKB1 (serine/threonine kinase) mutation status are limited.

Experimental Design: We analyzed the incidence of cancer in 419 individuals with Peutz-Jeghers syndrome, and 297 had documented STK11/LKB1 mutations.

Results: Ninety-six cancers were found among individuals with Peutz-Jeghers syndrome. The risk for developing cancer at ages 20, 30, 40, 50, 60, and 70 years was 2%, 5%, 17%, 31%, 60%, and 85%, respectively. The most common cancers represented in this analysis were gastrointestinal in origin, gastroesophageal, small bowel, colorectal, and pancreatic, and the risk for these cancers at ages 30, 40, 50, and 60 years was 1%, 9%, 15%, and 33%, respectively. In women with Peutz-Jeghers syndrome, the risk of breast cancer was substantially increased, being 8% and 31% at ages 40 and 60 years, respectively. Kaplan-Meier analysis showed that cancer risks were similar in Peutz-Jeghers syndrome patients with identified STK11/LKB1 mutations and those with no detectable mutation (log-rank test of difference {chi}2 = 0.62; 1 df; P = 0.43). Furthermore, the type or site of STK11/LKB1 mutation did not significantly influence cancer risk.

Conclusions: The results from our study provide quantitative information on the spectrum of cancers and risks of specific cancer types associated with Peutz-Jeghers syndrome.




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
M. Jansen, J. P. ten Klooster, G. J. Offerhaus, and H. Clevers
LKB1 and AMPK Family Signaling: The Intimate Link Between Cell Polarity and Energy Metabolism
Physiol Rev, July 1, 2009; 89(3): 777 - 798.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
B. H. Thiers, R. E. Sahn, and J. P. Callen
Cutaneous Manifestations of Internal Malignancy
CA Cancer J Clin, March 3, 2009; (2009) caac.20005v1.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
R. G. Jones and C. B. Thompson
Tumor suppressors and cell metabolism: a recipe for cancer growth
Genes & Dev., March 1, 2009; 23(5): 537 - 548.
[Abstract] [Full Text] [PDF]


Home page
Acta Biochim Biophys SinHome page
D. Fan, C. Ma, and H. Zhang
The molecular mechanisms that underlie the tumor suppressor function of LKB1
Acta Biochim Biophys Sin, February 1, 2009; 41(2): 97 - 107.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
U. Shah, N. E. Sharpless, and D. N. Hayes
LKB1 and Lung Cancer: More Than the Usual Suspects
Cancer Res., May 15, 2008; 68(10): 3562 - 3565.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. H. Lu, W. Wu, B. Dave, B. M. Slomovitz, T. W. Burke, M. F. Munsell, R. R. Broaddus, and C. L. Walker
Loss of Tuberous Sclerosis Complex-2 Function and Activation of Mammalian Target of Rapamycin Signaling in Endometrial Carcinoma
Clin. Cancer Res., May 1, 2008; 14(9): 2543 - 2550.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. Contreras, S. Gurumurthy, J. M. Haynie, L. J. Shirley, E. A. Akbay, S. N. Wingo, J. O. Schorge, R. R. Broaddus, K.-K. Wong, N. Bardeesy, et al.
Loss of Lkb1 Provokes Highly Invasive Endometrial Adenocarcinomas
Cancer Res., February 1, 2008; 68(3): 759 - 766.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Gurumurthy, A. F. Hezel, J. H. Berger, M. W. Bosenberg, and N. Bardeesy
LKB1 Deficiency Sensitizes Mice to Carcinogen-Induced Tumorigenesis
Cancer Res., January 1, 2008; 68(1): 55 - 63.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. L. Rufener, K. Koujok, B. J. McKenna, and M. Walsh
Best Cases from the AFIP: Small Bowel Intussusception Secondary to Peutz-Jeghers Polyp
RadioGraphics, January 1, 2008; 28(1): 284 - 288.
[Full Text] [PDF]


Home page
NEJMHome page
T. E. Baudendistel, A. K. Haase, and F. Fitzgerald
The Leading Diagnosis -- A 23-year-old black woman presented to the emergency department with diffuse, colicky abdominal pain of 1 hour's duration
N. Engl. J. Med., December 6, 2007; 357(23): 2389 - 2393.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.